|
HBEGF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.144000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.374610E-01 |
| Normal-vs-Stage2 |
6.258000E-01 |
| Normal-vs-Stage3 |
8.962800E-01 |
| Normal-vs-Stage4 |
4.944000E-01 |
| Stage1-vs-Stage2 |
6.262800E-01 |
| Stage1-vs-Stage3 |
7.545500E-02 |
| Stage1-vs-Stage4 |
3.741500E-02 |
| Stage2-vs-Stage3 |
5.571000E-01 |
| Stage2-vs-Stage4 |
3.567600E-01 |
| Stage3-vs-Stage4 |
5.293200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.278300E-02 |
| Normal-vs-AfricanAmerican |
8.091800E-01 |
| Normal-vs-Asian |
7.487600E-01 |
| Caucasian-vs-AfricanAmerican |
5.046200E-01 |
| Caucasian-vs-Asian |
3.244800E-01 |
| AfricanAmerican-vs-Asian |
9.867400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.491800E-01 |
| Normal-vs-Female |
1.486770E-01 |
| Male-vs-Female |
1.695990E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.548200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.249400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.490400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.220600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.689730E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.255700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.106600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.534400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.033200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.996400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.767200E-01 |
| Classical-VS-Follicular |
2.6888000004277E-07 |
| Classical-VS-Other |
7.772200E-01 |
| Classical-VS-Normal |
5.301900E-02 |
| Tall-VS-Follicular |
2.265600E-01 |
| Tall-VS-Other |
8.485400E-01 |
| Tall-VS-Normal |
9.934600E-01 |
| Follicular-VS-Other |
4.820200E-01 |
| Follicular-VS-Normal |
1.725840E-02 |
| Other-VS-Normal |
8.523200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.430200E-01 |
| Normal-vs-N1 |
4.897400E-01 |
| N0-vs-N1 |
2.990400E-01 |
|
|
